Press release
D-Mannose Market Projected To Exhibit 2.9% CAGR, Ultimately Leading To Size Of US$ 1.72 Billion By 2034
D-Mannose, a naturally occurring sugar, has gained significant traction in recent years due to its potential health benefits, particularly in the prevention and treatment of urinary tract infections (UTIs). As of 2024, the D-Mannose Market is estimated to reach US$ 1.3 billion and is projected to grow to US$ 1.72 billion by 2034, driven by a compound annual growth rate (CAGR) of 2.9%. This article delves into the factors contributing to this market growth, the key players, regional dynamics, and future trends.Get Free Sample Research Report:
https://www.factmr.com/connectus/sample?flag=S&rep_id=9923
D-Mannose is a simple sugar related to glucose and is found in various fruits and vegetables, including cranberries, apples, and oranges. It plays a crucial role in human metabolism, and its primary health benefit is its ability to prevent UTIs by inhibiting the adherence of bacteria, such as Escherichia coli (E. coli), to the urinary tract lining. This property makes D-Mannose a popular supplement, particularly among individuals prone to recurrent UTIs.
Market Drivers:
Health Benefits and Increasing Awareness The rising awareness of the health benefits of D-Mannose is a significant driver of market growth. With more consumers seeking natural and effective remedies for UTIs, D-Mannose has emerged as a preferred alternative to antibiotics, which can have adverse side effects and lead to antibiotic resistance.
Growing Incidence of UTIs The increasing prevalence of UTIs, particularly among women, is fueling the demand for D-Mannose. According to the National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK), UTIs account for nearly 8.1 million visits to healthcare providers annually in the United States alone. This high incidence rate underscores the need for effective preventive measures, thereby boosting the D-Mannose market.
Rise in Dietary Supplements The global dietary supplements market is expanding rapidly, driven by the growing interest in health and wellness. D-Mannose is a popular ingredient in these supplements, contributing to its market growth. Consumers are increasingly opting for preventive healthcare measures, which include the use of natural supplements like D-Mannose.
Technological Advancements in Production Advances in extraction and production technologies have made D-Mannose more accessible and affordable. Improved extraction techniques from natural sources and the development of synthetic D-Mannose have increased the availability of high-quality products, thereby supporting market growth.
Market Restraints:
High Cost of Production Despite technological advancements, the production of high-quality D-Mannose remains costly. The extraction process from natural sources is complex and resource-intensive, which can limit the market's growth potential, particularly in price-sensitive regions.
Availability of Alternatives The market faces competition from other natural remedies and synthetic drugs used to prevent and treat UTIs. While D-Mannose is effective, some consumers may prefer alternative treatments, such as cranberry supplements or antibiotics, which can impact market growth.
Regional Analysis:
North America North America dominates the D-Mannose market, driven by high awareness of its health benefits and the rising incidence of UTIs. The United States, in particular, has a well-established market for dietary supplements, which includes D-Mannose. The region's robust healthcare infrastructure and proactive approach to preventive healthcare contribute to market growth.
Europe Europe is another significant market for D-Mannose, with countries like Germany, France, and the United Kingdom leading in consumption. The region's stringent regulatory standards ensure the availability of high-quality D-Mannose products. Additionally, the increasing focus on natural and preventive healthcare solutions supports market expansion.
Request For Free Customization Report:
https://www.factmr.com/connectus/sample?flag=RC&rep_id=9923
Asia-Pacific The Asia-Pacific region is expected to witness the fastest growth during the forecast period. The rising healthcare awareness, increasing disposable income, and growing incidence of UTIs drive the demand for D-Mannose. Countries like China, Japan, and India are key markets, with a significant potential for growth.
Rest of the World The market in the rest of the world, including Latin America, the Middle East, and Africa, is gradually gaining traction. Increasing healthcare awareness and the adoption of dietary supplements contribute to the growth of the D-Mannose market in these regions.
Key Players:
The D-Mannose market is highly competitive, with several key players driving innovation and growth. Some of the prominent companies in the market include:
Now Health Group, Inc. Now Health Group, Inc. is a leading player in the D-Mannose market, known for its high-quality dietary supplements. The company's focus on natural health products and extensive distribution network contributes to its strong market presence.
Atrium Innovations Inc. Atrium Innovations Inc. is another major player, offering a wide range of health products, including D-Mannose supplements. The company's commitment to research and development and its focus on innovative healthcare solutions position it as a key player in the market.
Jarrow Formulas, Inc. Jarrow Formulas, Inc. is renowned for its dietary supplements and nutritional products. The company's emphasis on scientific research and high-quality formulations makes it a significant player in the D-Mannose market.
Hänseler AG Hänseler AG, a Swiss company, is known for its pharmaceutical and healthcare products, including D-Mannose. The company's stringent quality standards and focus on customer satisfaction contribute to its market leadership.
Browse Full Report @ https://www.factmr.com/report/d-mannose-market
Market Trends:
Increasing Demand for Natural Remedies The trend towards natural and holistic healthcare solutions is driving the demand for D-Mannose. Consumers are increasingly seeking natural remedies for common health issues, such as UTIs, to avoid the side effects associated with synthetic drugs.
Expansion of E-commerce The growth of e-commerce platforms has made D-Mannose products more accessible to consumers worldwide. Online retailers offer a wide range of D-Mannose supplements, making it convenient for consumers to purchase these products from the comfort of their homes.
Product Innovation Companies are focusing on product innovation to cater to the diverse needs of consumers. This includes the development of new formulations, such as D-Mannose in combination with other natural ingredients, to enhance its efficacy and appeal to a broader consumer base.
Rising Geriatric Population The global aging population is another factor contributing to the market growth. Older adults are more prone to UTIs and other health issues, increasing the demand for preventive measures like D-Mannose supplements.
Future Outlook:
The D-Mannose market is poised for steady growth over the next decade, driven by increasing health awareness, the rising incidence of UTIs, and the growing demand for natural remedies. Companies in the market are likely to focus on expanding their product portfolios, improving production technologies, and exploring new markets to sustain growth.
Related Publish by Fact.MR Industry:
Hot Beverages (Coffee & Tea) Market:
https://www.factmr.com/report/hot-beverages-market
Cocoa Market:
https://www.factmr.com/report/44/cocoa-market
Non-Alcoholic Wine Market:
https://www.factmr.com/report/4532/non-alcoholic-wine-market
Grassfed Meat Market:
https://www.factmr.com/report/655/grassfed-meat-market
𝐂𝐨𝐧𝐭𝐚𝐜𝐭:
US Sales Office :
11140 Rockville Pike
Suite 400
Rockville, MD 20852
United States
Tel: +1 (628) 251-1583
E-Mail: sales@factmr.com
𝐀𝐛𝐨𝐮𝐭 𝐅𝐚𝐜𝐭.𝐌𝐑
We are a trusted research partner of 80% of fortune 1000 companies across the globe. We are consistently growing in the field of market research with more than 1000 reports published every year. The dedicated team of 400-plus analysts and consultants is committed to achieving the utmost level of our client's satisfaction.
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release D-Mannose Market Projected To Exhibit 2.9% CAGR, Ultimately Leading To Size Of US$ 1.72 Billion By 2034 here
News-ID: 3579213 • Views: …
More Releases from Fact.MR

Insulated Drinkware Market to Hit USD 2.57 Billion by 2033 | YETI, Thermos L.L.C …
The global insulated drinkware market was valued at US$ 1.39 billion in 2023 and is forecasted to expand at a 6.3% CAGR over the next ten years. Worldwide sales of insulated drinkware are projected to reach US$ 2.57 billion by 2033-end.This robust growth is driven by increasing consumer awareness of sustainability, rising participation in outdoor activities, and the growing demand for reusable, eco-friendly products amid bans on single-use plastics.
The market…

Digital Twin Market is Growing at a CAGR of 34.3% d by 2033 | Key Players: ABB L …
Digital Twin Market is valued at USD 5 billion in 2023 and is projected to expand at a compound annual growth rate (CAGR) of 34.3%, reaching USD 95 billion by 2033. This explosive growth is driven by the increasing adoption of digital twins across industries to optimize operations, reduce costs, and enhance decision-making through virtual replicas of physical assets. Digital twins integrate IoT, AI, and data analytics to simulate real-world…

Hemato Oncology Testing Market is Forecasted to Reach USD 23.64 Billion by 2033 …
The global hemato oncology testing market is valued at USD 4.33 billion in 2023 and is projected to expand at a compound annual growth rate (CAGR) of 18.5%, reaching USD 23.64 billion by 2033. This rapid growth is driven by the increasing prevalence of blood-related cancers, such as lymphoma and leukemia, and advancements in diagnostic technologies like next-generation sequencing (NGS) and polymerase chain reaction (PCR). Hemato oncology testing plays a…

Osseointegration Implants Market is Anticipated to Reach USD 6.85 Billion by 203 …
Osseointegration Implants Market is poised for robust growth, with its valuation projected to rise from USD 3.17 billion in 2025 to USD 6.85 billion by 2035, reflecting a compound annual growth rate (CAGR) of 8%. This expansion is driven by the increasing prevalence of orthopedic and dental disorders, such as osteoarthritis, rheumatoid arthritis, and edentulism, which necessitate advanced implant solutions. Osseointegration implants, which fuse directly with bone to provide stable…
More Releases for UTIs
Urinary Tract Infection (UTI) Treatment Market to Reach US$ 15.08 Bn by 2032, Re …
Urinary tract infections (UTIs) represent one of the most common bacterial infections affecting individuals across the globe. The treatment market for UTIs has been experiencing significant growth, driven by a combination of factors such as antibiotic resistance, an aging population, and the increasing global awareness about symptoms. With advancements in diagnostic tools and pharmaceutical innovations, the UTI treatment market is expected to continue expanding throughout the next decade. In this…
Uncomplicated Urinary Tract Infection (UTI) Treatment Market Set to Reach US$11. …
𝐌𝐚𝐫𝐤𝐞𝐭 𝐎𝐮𝐭𝐥𝐨𝐨𝐤:
Urinary tract infections (UTIs) are among the most common bacterial infections globally, affecting millions of individuals each year. UTIs are categorized into two types: complicated and uncomplicated. While complicated UTIs tend to be more severe and associated with underlying medical conditions, uncomplicated UTIs are typically simpler to treat and occur in otherwise healthy individuals. The uncomplicated UTI treatment market is witnessing robust growth, with an expected market size reaching…
Uncomplicated Urinary Tract Infection (UTI) Treatment Market Growing Demand for …
Introduction
Urinary tract infections (UTIs) are among the most common bacterial infections affecting individuals worldwide, especially women. They occur when harmful bacteria enter the urinary tract, leading to inflammation and discomfort. While most UTIs are uncomplicated, meaning they are limited to the lower urinary tract (bladder and urethra), their frequency and impact on daily life highlight the importance of effective treatments. The UTI treatment market is experiencing significant growth, driven by…
Ultimate Guide to UTI Prevention and Care for Women Unveiled by All-Inclusive Pr …
Image: https://www.getnews.info/wp-content/uploads/2024/09/1727265867.jpeg
MIAMI LAKES, FLORIDA - September 25, 2024 - All-Inclusive Preventive Care LLC [https://www.allinclusive.care/uti-women/] has released a detailed guide for women on urinary tract infection (UTI) prevention and care. This resource aims to educate women on UTI prevention and offer practical advice on maintaining urinary health.
Urinary tract infections (UTIs) are a common condition that affect millions of women each year. The guide from All-Inclusive Preventive Care explains what a UTI…
Global Automated Urine Particle Analyzer Market Set to Grow at a CAGR of 7.5% fr …
The global Automated Urine Particle Analyzer market is set for substantial growth at a Compound Annual Growth Rate (CAGR) of 7.5% from this year till 2030, according to a latest research report by Dataintelo. The ascendancy of this market is primarily fostered by the escalating prevalence of urinary tract infections (UTIs) paired with the rising demand for point-of-care diagnostics.
The fully automatic segment is anticipated to dominate the market during the…
With 4.56% CAGR, Urinary Tract Infection Therapeutics Market Size Worth USD 11,6 …
Facts and Influences A new report from Market Research is titled "Urinary Tract Infection Therapeutics Market- By Age Group (Children, Adults & Elderly), By Indication (Complicated, Uncomplicated, Recurrent, Catheter-related), By Distribution Network (E-commerce, Hospital Pharmacies, Retail Pharmacies), By Drug Group (Azoles and Amphotericin B, Cephalosporin, Quinolones, Nitrofurans, Penicillin The global market for therapies for urinary tract infections was estimated to be worth USD 8,935 million in 2020 and is projected…